Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17359476 | 0.92 | P2RY2 (0.30) | P2RY2 | |
| SCHEMBL18161325 | 0.91 | P2RY2 (0.30) | P2RY2 | |
| SCHEMBL16949606 | 0.91 | RXFP1 (0.30) | P2RY2 | |
| SCHEMBL15765744 | 0.91 | P2RY2 (0.30) | P2RY2 | |
| SCHEMBL15297346 | 0.91 | P2RY2 (0.30) | P2RY2 | |
| SCHEMBL15727323 | 0.90 | — | — | |
| SCHEMBL15933540 | 0.90 | — | — | |
| SCHEMBL19646631 | 0.87 | P2RY2 (0.39) | P2RY2 | |
| SCHEMBL18950205 | 0.85 | P2RY14 (0.30) | — | |
| SCHEMBL14948854 | 0.85 | P2RY2 (0.30) | P2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9221891-B2 | In vivo production of proteins | MODERNA THERAPEUTICS, INC. (US) | 2015-12-29 | — | — | US | disclosed |
| US-20150111248-A1 | IN VIVO PRODUCTION OF PROTEINS | MODERNA THERAPEUTICS, INC. (US) | 2015-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150111248-A1 | IN VIVO PRODUCTION OF PROTEINS | MSH2, POLRMT, POLN | P2RY2 3346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.